Fundraising FoxBioAdvance — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers.
AI & Machine LearningBiotechHealthtechBrooklyn, US
Stacy Blain(Founder, CEO)inLisaMarie Casey(President and Manager)Dustin Mraz(Executive Board Member / Co-founder)
BoardJason Mraz(Executive Board Member)in
Co-investorsCatalytic Impact FoundationCreative Destruction Lab (CDL)Raptor Group
HealthtechWilmington, US
Christopher Berlind(Executive Officer, Director)inDavid Lindsay, Jr.(Executive Officer, Director)
BoardGary Kurtzman(Director)
Co-investorsCota CapitalDorm Room
Wellsheet builds a clinical workflow support system that uses machine learning to predict physicians' information needs and present a structured, comprehensive view of patient data at the point of care.
AI & Machine LearningDigital HealthHealthtechNew York, US
Craig Limoli(Executive Officer, Director, Promoter)inDaniel Larkin(Executive Officer, Director, Promoter)
Co-investorsBeni Venture CapitalReal-Life InnovationsREDO VenturesSpringTide VenturesStartXNewark Venture Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.